NSE:SUNPHARMA this can be a littil longer consolidation buy only above 805 clsoing SL 660 T 820, 845, 870, 900+
Stock Name: SUNPHARMA Pattern Name: Falling Broadening Wedge Pattern Current Price: 679.60 Projected Pattern Target: 690+
After the rally it is forming a nice bullish flag pattern if it crosses above 801 it will be good for long position
The stock has failed to breakout the upper trend line and might undergo a correction. Trade is supported by Resistance and Upper Trendline. Risk Reward Ratio - 1:1 SL is placed above all time high & the upper trendline. The target is placed near lower bollinger band. Daily PSAR has also signaled a reversal.
The stock has broken out and retested the upper trendline and found support. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below the support zone and the previously upper Trendline. The target is placed based on fundamentals.
Dear trader, If u look at the chart of SUNPHARMA (analysis based intraday only) the SUNPHARMA Buy at 782 and Target at 794 Best Buy at 780. Our Best Buy is based on high quality research and when the instrument reaches this level , itâ€™s a jackpot trade. Best Buy level might be executed or might not be executed. The chart clearly indicates Bullish Trend you can...
Sun Pharma is heading towards 850-860. Will give breakout in next few trading session.
Sun Pharma trading above major resistance zone as well as above(Breakout) the ascending channel after that its trading in range. Add it in your watchlist for breakout.
SunPharma consolidated for a week and ready for the breakout. During the consolidation period, it tried to break the upper resistance and failed. One can easily enter if the stock BreakOut. We can expect the breakout tomorrow. Plan your trade. #educationPurposeOnly
It has formed bullish engulfing at the resistance line. looks like the growth is not over yet.
Dear trader, If u look at the chart of SUNPHARMA (analysis based intraday only) the SUNPHARMA Buy at 770 and Target at 785 Best Buy at 768. Our Best Buy is based on high quality research and when the instrument reaches this level , itâ€™s a jackpot trade. Best Buy level might be executed or might not be executed. The chart clearly indicates Bullish Trend you can...
Book profit and exit if you are a medium-term investor. Great resistance from the trend line . the price will see a downtrend for few days. After correction around 710 take a new entry.
SunPharma - 799 / 845 by 2nd / 3rd Aug.
Trend lines can be used to trade, if it closes beyond those trend lines trade can be taken respectively
as i posted sunpharma so the close look pattern for sunpharma on 1d tf
sun pharma is ready for another swing as it is channel also pharma sectors are leading and also it has crossed anchored vwap and breaked the trend line also retested on trend line and is on the support of v-profile and also on the day chart valid bullish engulfing pattern is made which is another confirmation so lets see for HH and then enter
Buy recommendation on sun pharma at current price. Target expected at least 25% from CMP
Enterprise Value/EBITDA, TTM â€”
Enterprise Value, FQ â€”
Market Cap â€” Basic â€”
Number of Employees â€”
Number of Shareholders â€”
Price/Earnings, TTM â€”
Price/Revenue, TTM â€”
Price/Book Ratio, FY â€”
Price/Sales Ratio, FY â€”
Current Ratio, FQ â€”
Debt to Equity, FQ â€”
Net Debt, FQ â€”
Quick Ratio, FQ â€”
Total Assets, FQ â€”
Total Debt, FQ â€”
Return on Assets, TTM â€”
Return on Equity, TTM â€”
Return on Invested Capital, TTM â€”
Revenue per Employee, TTM â€”
Average Volume (10 day) â€”
Beta - 1 Year â€”
Price - 52 Week High â€”
Price - 52 Week Low â€”
Dividends Paid, FY â€”
Dividends per Share, FY â€”
Expected Annual Dividends â€”
Dividends Yield â€”
Net Margin, TTM â€”
Gross Margin, TTM â€”
Operating Margin, TTM â€”
Pretax Margin, TTM â€”
Basic EPS, Net Income â€”
Earnings per Share, Basic, TTM â€”
EBITDA, TTM â€”
Gross Profit, FY â€”
Last Annual EPS â€”
Last Annual Revenue, FY â€”
Net Income, FY â€”
Total Revenue, FY â€”
Free Cash Flow, TTM â€”
Sector: Health Technology
Industry: Pharmaceuticals: Major
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.
Find us at the office
Zawodniak- Bushar street no. 43, 41415 Nouakchott, Mauritania
Give us a ring
+77 583 658 542
Mon - Fri, 10:00-15:00